Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing Induction of Type II (M2) Monocytes/Macrophages in Patients Receiving Gilenya.

NCT02225977 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.

NCT NCT02225977
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02225977 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing Induction of Type II (M2) Monocytes/Macrophages in Patients Receiving Gilenya.
Lead sponsor
University of Southern California
Phase
Observational
Overall status
Completed
Start date
July 31, 2013
Completion date
April 30, 2017
Enrollment
125 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis